<?xml version="1.0" encoding="UTF-8"?>
<p>It is well established that more than one mechanism may be involved in intracellular drug delivery. The mechanisms involved in nano-based intracellular drug delivery include passive diffusion of free drug, non-specific phagocytosis of the nanocarrier, nanocarrier uptake by pinocytosis, and receptor-mediated endocytosis [
 <xref rid="B88-pharmaceutics-12-00171" ref-type="bibr">88</xref>]. In this section, we will discuss in particular how to overcome biological barriers such as mucus, skin, cell membrane and BBB in antiviral therapy.
</p>
